Skip to main content
Erschienen in: Surgical Endoscopy 2/2011

01.02.2011

Malignant esophageal dysphagia palliation using insertion of a covered Ultraflex stent without fluoroscopy: a prospective observational study

verfasst von: Georgia Lazaraki, Panagiotis Katsinelos, Andreas Nakos, Grigoris Chatzimavroudis, Ioannis Pilpilidis, Dimitrios Paikos, Dimitrios Tzilves, Ioannis Katsos

Erschienen in: Surgical Endoscopy | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

This study aimed to investigate the efficacy and safety of placing self-expandable metal stents (SEMSs) without fluoroscopy for palliation of malignant esophageal or esophagogastric strictures.

Methods

From January 2003 to June 2008, a prospective observational study investigated the placement of covered proximal-release Ultraflex stents without fluoroscopy in nonoperable malignant esophageal and esophagogastric strictures. The technical success as well as the early and late complications (perforation, migration, severe gastroesophageal reflux, hematemesis, and reobstruction due to tissue ingrowth or overgrowth) were recorded. Dysphagia before and after stent placement was scored on a 5-point scale. All the patients were observed monthly in the outpatient clinic or by telephone contact until death.

Results

The study enrolled 89 patients (16 women; mean age, 69.54 ± 7.1 years) with dysphagia due to inoperable esophageal or esophagogastric malignant strictures (29 squamous cell cancers, 52 adenocarcinomas, and 8 obstructive malignant extrinsic compressions). The mean stricture length was 6.2 ± 2.8 cm. Endoscopic deployment was achieved for 83 patients (93.2%), with accurate stent positioning in all the patients except one. An adequate relief of symptoms was noted for 82 of the patients (92.1%). During the follow-up period, 36 patients (43.4%) had recurrent dysphagia, caused by tumor overgrowth in 32 cases and stent migration in 4 cases, after an average time of 82 days (range 67–216 days). A stent-in-stent procedure was performed in 27 cases. For two patients, a third stent-in-stent needed to be placed after 85 and 216 days, respectively.

Conclusion

In most cases, SEMSs can be accurately and safely positioned without fluoroscopy for palliative treatment of malignant esophageal dysphagia.
Literatur
1.
Zurück zum Zitat Simmons DT, Baron TH (2005) Endoluminal palliation. Gastrointest Endosc Clin North Am 15:467–484 viiiCrossRef Simmons DT, Baron TH (2005) Endoluminal palliation. Gastrointest Endosc Clin North Am 15:467–484 viiiCrossRef
2.
Zurück zum Zitat Luketich JD, Nguyen NT, Weigel TL, Keenan RJ, Ferson PF, Belani CP (1999) Photodynamic therapy for treatment of malignant dysphagia. Surg Laparosc Endosc Percutan Tech 9:171–175PubMed Luketich JD, Nguyen NT, Weigel TL, Keenan RJ, Ferson PF, Belani CP (1999) Photodynamic therapy for treatment of malignant dysphagia. Surg Laparosc Endosc Percutan Tech 9:171–175PubMed
3.
Zurück zum Zitat Im JP, Kang JM, Kim SG, Kim JS, Jung HC, Song IS (2008) Clinical outcomes and patency of self-expanding metal stents in patients with malignant upper gastrointestinal obstruction. Dig Dis Sci 53:938–945CrossRefPubMed Im JP, Kang JM, Kim SG, Kim JS, Jung HC, Song IS (2008) Clinical outcomes and patency of self-expanding metal stents in patients with malignant upper gastrointestinal obstruction. Dig Dis Sci 53:938–945CrossRefPubMed
4.
Zurück zum Zitat Verschuur EM, Homs MY, Steyerberg EW, Haringsma J, Wahab PJ, Kuipers EJ, Siersema PD (2006) A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients. Gastrointest Endosc 63:134–140CrossRefPubMed Verschuur EM, Homs MY, Steyerberg EW, Haringsma J, Wahab PJ, Kuipers EJ, Siersema PD (2006) A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients. Gastrointest Endosc 63:134–140CrossRefPubMed
5.
Zurück zum Zitat Siersema PD, Marcon N, Vakil N (2003) Metal stents for tumors of the distal esophagus and gastric cardia. Endoscopy 35:79–85CrossRefPubMed Siersema PD, Marcon N, Vakil N (2003) Metal stents for tumors of the distal esophagus and gastric cardia. Endoscopy 35:79–85CrossRefPubMed
6.
Zurück zum Zitat Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, van Lanschot JJ, Wijrdeman HK, Mulder CJ, Reinders JG, Boot H, Aleman BM, Kuipers EJ, Siersema PD (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364:1497–1504CrossRefPubMed Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, van Lanschot JJ, Wijrdeman HK, Mulder CJ, Reinders JG, Boot H, Aleman BM, Kuipers EJ, Siersema PD (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364:1497–1504CrossRefPubMed
7.
Zurück zum Zitat Austin AS, Khan Z, Cole AT, Freeman JG (2001) Placement of esophageal self-expanding metallic stents without fluoroscopy. Gastrointest Endosc 54:357–359CrossRefPubMed Austin AS, Khan Z, Cole AT, Freeman JG (2001) Placement of esophageal self-expanding metallic stents without fluoroscopy. Gastrointest Endosc 54:357–359CrossRefPubMed
8.
Zurück zum Zitat Ben Soussan E, Antonietti M, Lecleire S, Savoye G, Di Fiore F, Paillot B, Michel P, Ducrotté P, Lerebours E (2005) Palliative esophageal stent placement using endoscopic guidance without fluoroscopy. Gastroenterol Clin Biol 29:785–788CrossRefPubMed Ben Soussan E, Antonietti M, Lecleire S, Savoye G, Di Fiore F, Paillot B, Michel P, Ducrotté P, Lerebours E (2005) Palliative esophageal stent placement using endoscopic guidance without fluoroscopy. Gastroenterol Clin Biol 29:785–788CrossRefPubMed
9.
Zurück zum Zitat White RE, Mungatana C, Topazian M (2001) Esophageal stent placement without fluoroscopy. Gastrointest Endosc 53:348–351PubMed White RE, Mungatana C, Topazian M (2001) Esophageal stent placement without fluoroscopy. Gastrointest Endosc 53:348–351PubMed
10.
Zurück zum Zitat Wilkes EA, Jackson LM, Cole AT, Freeman JG, Goddard AF (2007) Insertion of expandable metallic stents in esophageal cancer without fluoroscopy is safe and effective: a 5-year experience. Gastrointest Endosc 65:923–929CrossRefPubMed Wilkes EA, Jackson LM, Cole AT, Freeman JG, Goddard AF (2007) Insertion of expandable metallic stents in esophageal cancer without fluoroscopy is safe and effective: a 5-year experience. Gastrointest Endosc 65:923–929CrossRefPubMed
11.
Zurück zum Zitat Rathore OI, Coss A, Patchett SE, Mulcahy HE (2006) Direct-vision stenting: the way forward for malignant oesophageal obstruction. Endoscopy 38:382–384CrossRefPubMed Rathore OI, Coss A, Patchett SE, Mulcahy HE (2006) Direct-vision stenting: the way forward for malignant oesophageal obstruction. Endoscopy 38:382–384CrossRefPubMed
12.
Zurück zum Zitat Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M (1998) Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 47:113–120CrossRefPubMed Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M (1998) Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 47:113–120CrossRefPubMed
13.
Zurück zum Zitat Singhvi R, Abbasakoor F, Manson JM (2000) Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method. Ann R Coll Surg Engl 82:243–248PubMed Singhvi R, Abbasakoor F, Manson JM (2000) Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method. Ann R Coll Surg Engl 82:243–248PubMed
14.
Zurück zum Zitat Baron TH (2007) Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin North Am 17:83–104 viiCrossRef Baron TH (2007) Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin North Am 17:83–104 viiCrossRef
15.
Zurück zum Zitat De Palma GD, di Matteo E, Romano G, Fimmano A, Rondinone G, Catanzano C (1996) Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc 43:478–482CrossRefPubMed De Palma GD, di Matteo E, Romano G, Fimmano A, Rondinone G, Catanzano C (1996) Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc 43:478–482CrossRefPubMed
16.
Zurück zum Zitat Dumonceau JM, Deviere J (1999) Self-expandable metal stents. Baillieres Best Pract Res Clin Gastroenterol 13:109–130CrossRefPubMed Dumonceau JM, Deviere J (1999) Self-expandable metal stents. Baillieres Best Pract Res Clin Gastroenterol 13:109–130CrossRefPubMed
17.
Zurück zum Zitat Evrard S, Le Moine O, Lazaraki G, Dormann A, El Nakadi I, Deviere J (2004) Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc 60:894–900CrossRefPubMed Evrard S, Le Moine O, Lazaraki G, Dormann A, El Nakadi I, Deviere J (2004) Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc 60:894–900CrossRefPubMed
18.
Zurück zum Zitat Lambert R (2007) Insertion of expandable metallic stents in esophageal cancer without fluoroscopy: is it safe? Gastrointest Endosc 65:929–931CrossRefPubMed Lambert R (2007) Insertion of expandable metallic stents in esophageal cancer without fluoroscopy: is it safe? Gastrointest Endosc 65:929–931CrossRefPubMed
19.
Zurück zum Zitat Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A (2003) A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 52:922–926CrossRefPubMed Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A (2003) A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 52:922–926CrossRefPubMed
20.
Zurück zum Zitat Law S, Tung PH, Chu KM, Wong J (1999) Self-expanding metallic stents for palliation of recurrent malignant esophageal obstruction after subtotal esophagectomy for cancer. Gastrointest Endosc 50:427–436CrossRefPubMed Law S, Tung PH, Chu KM, Wong J (1999) Self-expanding metallic stents for palliation of recurrent malignant esophageal obstruction after subtotal esophagectomy for cancer. Gastrointest Endosc 50:427–436CrossRefPubMed
21.
Zurück zum Zitat Mayoral W, Fleischer D, Salcedo J, Roy P, Al-Kawas F, Benjamin S (2000) Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc 51:556–559CrossRefPubMed Mayoral W, Fleischer D, Salcedo J, Roy P, Al-Kawas F, Benjamin S (2000) Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc 51:556–559CrossRefPubMed
22.
Zurück zum Zitat Wenger U, Johnsson E, Arnelo U, Lundell L, Lagergren J (2006) An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study. Surg Endosc 20:1675–1680CrossRefPubMed Wenger U, Johnsson E, Arnelo U, Lundell L, Lagergren J (2006) An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study. Surg Endosc 20:1675–1680CrossRefPubMed
23.
Zurück zum Zitat Siersema PD, Hop WC, van Blankenstein M, van Tilburg AJ, Bac DJ, Homs MY, Kuipers EJ (2001) A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 54:145–153CrossRefPubMed Siersema PD, Hop WC, van Blankenstein M, van Tilburg AJ, Bac DJ, Homs MY, Kuipers EJ (2001) A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 54:145–153CrossRefPubMed
24.
Zurück zum Zitat Siersema PD, Schrauwen SL, van Blankenstein M, Steyerberg EW, van der Gaast A, Tilanus HW, Dees J, Rotterdam Esophageal Tumor Study Group (2001) Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 54:579–586CrossRefPubMed Siersema PD, Schrauwen SL, van Blankenstein M, Steyerberg EW, van der Gaast A, Tilanus HW, Dees J, Rotterdam Esophageal Tumor Study Group (2001) Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 54:579–586CrossRefPubMed
25.
Zurück zum Zitat Ell C, May A, Hahn EG (1995) Gianturco-Z stents in the palliative treatment of malignant esophageal obstruction and esophagotracheal fistulas. Endoscopy 27:495–500CrossRefPubMed Ell C, May A, Hahn EG (1995) Gianturco-Z stents in the palliative treatment of malignant esophageal obstruction and esophagotracheal fistulas. Endoscopy 27:495–500CrossRefPubMed
26.
Zurück zum Zitat Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, Zuccaro G, Bosco JJ, Jones WF (2001) A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96:1791–1796CrossRefPubMed Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, Zuccaro G, Bosco JJ, Jones WF (2001) A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96:1791–1796CrossRefPubMed
27.
Zurück zum Zitat Homs MY, Steyerberg EW, Kuipers EJ, van der Gaast A, Haringsma J, van Blankenstein M, Siersema PD (2004) Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 36:880–886CrossRefPubMed Homs MY, Steyerberg EW, Kuipers EJ, van der Gaast A, Haringsma J, van Blankenstein M, Siersema PD (2004) Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 36:880–886CrossRefPubMed
28.
Zurück zum Zitat Kozarek RA, Raltz S, Brugge WR, Schapiro RH, Waxman I, Boyce HW, Baillie J, Branch MS, Stevens PD, Lightdale CJ, Lehman GA, Benjamin S, Fleischer DE, Axelrad A, Kortan P, Marcon N (1996) Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula. Gastrointest Endosc 44:562–567CrossRefPubMed Kozarek RA, Raltz S, Brugge WR, Schapiro RH, Waxman I, Boyce HW, Baillie J, Branch MS, Stevens PD, Lightdale CJ, Lehman GA, Benjamin S, Fleischer DE, Axelrad A, Kortan P, Marcon N (1996) Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula. Gastrointest Endosc 44:562–567CrossRefPubMed
29.
Zurück zum Zitat Shim CS, Cho YD, Moon JH, Kim JO, Cho JY, Kim YS, Lee JS, Lee MS (2001) Fixation of a modified covered esophageal stent: its clinical usefulness for preventing stent migration. Endoscopy 33:843–848CrossRefPubMed Shim CS, Cho YD, Moon JH, Kim JO, Cho JY, Kim YS, Lee JS, Lee MS (2001) Fixation of a modified covered esophageal stent: its clinical usefulness for preventing stent migration. Endoscopy 33:843–848CrossRefPubMed
30.
Zurück zum Zitat Siersema PD, Hop WC, van Blankenstein M, Dees J (2000) A new-design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. The Rotterdam Esophageal Tumor Study Group. Gastrointest Endosc 51:139–145CrossRefPubMed Siersema PD, Hop WC, van Blankenstein M, Dees J (2000) A new-design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. The Rotterdam Esophageal Tumor Study Group. Gastrointest Endosc 51:139–145CrossRefPubMed
31.
Zurück zum Zitat Verschuur EM, Repici A, Kuipers EJ, Steyerberg EW, Siersema PD (2008) New-design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 103:304–312CrossRefPubMed Verschuur EM, Repici A, Kuipers EJ, Steyerberg EW, Siersema PD (2008) New-design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 103:304–312CrossRefPubMed
32.
Zurück zum Zitat Vakil N, Gross U, Bethge N (1999) Human tissue responses to metal stents. Gastrointest Endosc Clin North Am 9:359–365 Vakil N, Gross U, Bethge N (1999) Human tissue responses to metal stents. Gastrointest Endosc Clin North Am 9:359–365
33.
Zurück zum Zitat Verschuur EM, Steyerberg EW, Kuipers EJ, Siersema PD (2007) Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc 65:592–601CrossRefPubMed Verschuur EM, Steyerberg EW, Kuipers EJ, Siersema PD (2007) Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc 65:592–601CrossRefPubMed
34.
Zurück zum Zitat Siersema PD, Homs MY, Kuipers EJ (2005) Large-diameter metal stents are associated with stent-related esophageal complications. Endoscopy 37:600CrossRefPubMed Siersema PD, Homs MY, Kuipers EJ (2005) Large-diameter metal stents are associated with stent-related esophageal complications. Endoscopy 37:600CrossRefPubMed
35.
Zurück zum Zitat Valbuena J (1984) Endoscopic palliative treatment of esophageal and cardial cancer: a new antireflux prosthesis: a study of 40 cases. Cancer 53:993–998CrossRefPubMed Valbuena J (1984) Endoscopic palliative treatment of esophageal and cardial cancer: a new antireflux prosthesis: a study of 40 cases. Cancer 53:993–998CrossRefPubMed
Metadaten
Titel
Malignant esophageal dysphagia palliation using insertion of a covered Ultraflex stent without fluoroscopy: a prospective observational study
verfasst von
Georgia Lazaraki
Panagiotis Katsinelos
Andreas Nakos
Grigoris Chatzimavroudis
Ioannis Pilpilidis
Dimitrios Paikos
Dimitrios Tzilves
Ioannis Katsos
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 2/2011
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-010-1236-2

Weitere Artikel der Ausgabe 2/2011

Surgical Endoscopy 2/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.